Revere Partners, an institutional venture capital fund investing at the intersection of health and oral health technology, announced it will return to the Yankee Dental Congress with its fifth consecutive “Future of Dentistry Pavilion.”
The 2026 pavilion, located at Booth #2034, will operate under the theme “Liquid Gold,” highlighting saliva as a vital diagnostic medium and biological driver of overall health, as well as its growing role in regenerative dental technologies.
The Revere Innovation Pavilion will showcase a curated group of early- and growth-stage companies exploring saliva-based solutions from clinical, scientific, workflow, and commercial perspectives. The focus reflects increasing interest in medical-dental integration and whole-person care.
“It’s an honor to collaborate once again with the Yankee Dental Congress, as we share a strong mutual interest in accelerating the adoption of dental technology,” said Dr. Jeremy Krell, founder of Revere Partners.
This year’s Future of Dentistry Pavilion will feature companies leveraging saliva to support continuous health monitoring, early oral cancer detection, regenerative therapies, and implant stabilization. Participating innovators include:
HysensBio, which develops regenerative technologies for dentin and periodontal tissues to promote biologically driven healing.
Lura Health, which focuses on saliva-based diagnostics and continuous monitoring to identify disease risk earlier and enable personalized care.
OrisDx, which advances biomarker-driven diagnostic tools for early oral cancer detection.
RevBio, developer of Tetranite®, a synthetic bone adhesive designed to stabilize dental implants and craniofacial bone structures.
Over the past five years, Revere Partners’ presence at the Yankee Dental Congress has introduced dozens of startups to clinicians, industry leaders, and strategic partners seeking next-generation solutions in oral and systemic health.
“Our goal has always been to provide meaningful exposure to companies driving patient-centered care, addressing critical provider gaps, and advancing medical-dental integration,” Krell said.
